Cargando…

Immuno-dominant dengue NS1 peptides as antigens for production of monoclonal antibodies

Synthetic peptides have recently become common as antigens for antibody production. Peptides are short chains of amino acids that can be used to elicit an immune response. The immunogenicity of the peptide antigens varies depending on the length, charge, solubility, and amino acids contained in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Munasinghe, Erandi, Athapaththu, Maheshi, Abeyewickreme, Wimaladharma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635855/
https://www.ncbi.nlm.nih.gov/pubmed/36339720
http://dx.doi.org/10.3389/fmolb.2022.935456
_version_ 1784824805339430912
author Munasinghe, Erandi
Athapaththu, Maheshi
Abeyewickreme, Wimaladharma
author_facet Munasinghe, Erandi
Athapaththu, Maheshi
Abeyewickreme, Wimaladharma
author_sort Munasinghe, Erandi
collection PubMed
description Synthetic peptides have recently become common as antigens for antibody production. Peptides are short chains of amino acids that can be used to elicit an immune response. The immunogenicity of the peptide antigens varies depending on the length, charge, solubility, and amino acids contained in the peptide sequence. Dengue NS1 protein is an important target antigen in the early detection of dengue infection. In this study, peptides corresponding to a highly conserved region from the dengue NS1 region were designed and synthesized. Balb/C mice were immunized against each peptide and spleen cells extracted from the immunized mice were fused with NS0 murine myeloma cells. Hybridoma clones obtained from the fusions were tested against peptides using ELISA. Out of 1,830 growing clones, 28 clones produced antibodies reacting with dengue NS1 peptides. A purified monoclonal antibody reacting with all four peptides was tested for reactivity with dengue NS1 native protein using dengue-confirmed serum and urine samples. The monoclonal antibody shows significant reactivity with both serum and urine. The findings of the current research can be used to detect dengue infection using urine, which ultimately results in the prevention of dengue epidemics through painless diagnosis, following treatment, and patient management to safeguard human and economic wellness.
format Online
Article
Text
id pubmed-9635855
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96358552022-11-05 Immuno-dominant dengue NS1 peptides as antigens for production of monoclonal antibodies Munasinghe, Erandi Athapaththu, Maheshi Abeyewickreme, Wimaladharma Front Mol Biosci Molecular Biosciences Synthetic peptides have recently become common as antigens for antibody production. Peptides are short chains of amino acids that can be used to elicit an immune response. The immunogenicity of the peptide antigens varies depending on the length, charge, solubility, and amino acids contained in the peptide sequence. Dengue NS1 protein is an important target antigen in the early detection of dengue infection. In this study, peptides corresponding to a highly conserved region from the dengue NS1 region were designed and synthesized. Balb/C mice were immunized against each peptide and spleen cells extracted from the immunized mice were fused with NS0 murine myeloma cells. Hybridoma clones obtained from the fusions were tested against peptides using ELISA. Out of 1,830 growing clones, 28 clones produced antibodies reacting with dengue NS1 peptides. A purified monoclonal antibody reacting with all four peptides was tested for reactivity with dengue NS1 native protein using dengue-confirmed serum and urine samples. The monoclonal antibody shows significant reactivity with both serum and urine. The findings of the current research can be used to detect dengue infection using urine, which ultimately results in the prevention of dengue epidemics through painless diagnosis, following treatment, and patient management to safeguard human and economic wellness. Frontiers Media S.A. 2022-10-21 /pmc/articles/PMC9635855/ /pubmed/36339720 http://dx.doi.org/10.3389/fmolb.2022.935456 Text en Copyright © 2022 Munasinghe, Athapaththu and Abeyewickreme. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Molecular Biosciences
Munasinghe, Erandi
Athapaththu, Maheshi
Abeyewickreme, Wimaladharma
Immuno-dominant dengue NS1 peptides as antigens for production of monoclonal antibodies
title Immuno-dominant dengue NS1 peptides as antigens for production of monoclonal antibodies
title_full Immuno-dominant dengue NS1 peptides as antigens for production of monoclonal antibodies
title_fullStr Immuno-dominant dengue NS1 peptides as antigens for production of monoclonal antibodies
title_full_unstemmed Immuno-dominant dengue NS1 peptides as antigens for production of monoclonal antibodies
title_short Immuno-dominant dengue NS1 peptides as antigens for production of monoclonal antibodies
title_sort immuno-dominant dengue ns1 peptides as antigens for production of monoclonal antibodies
topic Molecular Biosciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635855/
https://www.ncbi.nlm.nih.gov/pubmed/36339720
http://dx.doi.org/10.3389/fmolb.2022.935456
work_keys_str_mv AT munasingheerandi immunodominantdenguens1peptidesasantigensforproductionofmonoclonalantibodies
AT athapaththumaheshi immunodominantdenguens1peptidesasantigensforproductionofmonoclonalantibodies
AT abeyewickremewimaladharma immunodominantdenguens1peptidesasantigensforproductionofmonoclonalantibodies